Cbd

CBD watchdog: Over half of coffee, tea have inaccurate CBD levels

28-Sep-2021 By Danielle Masterson

When compared to past results, the latest batch of tests indicate the industry is slowly improving over time.

Lawyer: FDA’s ongoing refusal to act on CBD impacts trademark laws

22-Sep-2021 By Stephen Daniells

The ongoing inaction by the US Food and Drug Administration over CBD (cannabidiol) in foods and dietary supplements is having a negative impact on trademark laws, says an industry lawyer.

Pro skateboarder launches CBD water with Vertical Wellness

16-Sep-2021 By Danielle Masterson

The partnership has spawned a product extension into the sparkling water category.

NutraWomen Wednesday: Pelin Thorogood, co-founder & executive chair of Radicle Science

15-Sep-2021 By Danielle Masterson

Pelin Thorogood is the co-founder and executive chair of Radicle Science, a health tech B-corp that combines market research, scientific rigor and technology with a focus on the CBD space.

NutraCast: PureForm Global on making CBD from orange peel

27-Aug-2021 By Danielle Masterson

As popular and as in demand CBD is, there is a huge chunk of the population who can’t see what the fuss is all about. Why? Because CBD products made from hemp could contain THC, a molecule that will lead to failed drug tests.
But there may be...

How TreeHouse Biosciences is helping brands with its patented THC remediation technology

23-Aug-2021 By Danielle Masterson

Keeping the THC within bounds in full spectrum hemp extracts is creating an opportunity for a company that is offering a remediation service.

Must-have ingredients to include in your spring 2022 products

16-Aug-2021 By Danielle Masterson

Our everyday habits and behaviors have dramatically shifted in the past two years and they continue to do so—including our dietary supplements routine. So what trends will be left in 2021 and what will roll over into 2022?

CV Sciences’ Q2 revenue rebounds after challenging Q1

13-Aug-2021 By Stephen Daniells

CBD products manufacturer CV Sciences has recorded quarter-on-quarter increases in revenue, with increasing retail distribution and a “strong” innovation pipeline leading to bullish predictions for the rest of 2022.

NutraWomen Wednesday: Nicole Brown, Chief Innovation Officer of Open Book Extracts

04-Aug-2021 By Danielle Masterson

From a marketing executive in the consumer and lifestyle space to technology and now CBD, Nicole Brown, Chief Innovation Officer of Open Book Extracts, says she became interested in the science behind cannabinoids. Her fascination ultimately led her to...

CBD from orange peels: A different CBD story

03-Aug-2021 By Danielle Masterson

A new CBD made from orange peel could signal a breakthrough for the industry and offer access that was once unimaginable.

Report: CBD prices decreasing across the industry

19-Jul-2021 By Danielle Masterson

The research also found colossal disparities among brands, underscoring the inconsistencies in pricing.

NutraCast Podcast: Chris Petersen brings entrepreneurship to Ocean Spray

16-Jul-2021 By Danielle Masterson

CarryOn is a new line of CBD sparkling waters developed by Ocean Spray’s Lighthouse Incubator. CarryOn’s Managing Director, Christopher Petersen, joined the NutraCast to discuss the innovation Incubator and explain how he went from being an army officer...

Schumer bill mandates legal pathway for CBD supplements, directs FDA to set safe upper exposure limit

15-Jul-2021 By Hank Schultz

A bill put forward by Senate Majority leader Chuck Schumer, D-NY, to decriminalize marijuana includes language on CBD that has been welcomed by supplement industry stakeholders.

NutraCast:Tracking CBD experiences in real-time with Releaf App

09-Jul-2021 By Danielle Masterson

More and more companies are using apps to gain insights on their respective industries. With the right data inputs, technology can improve decision making and help company leaders zero in on trends. The Releaf App is one such application that individuals...

NutraCast: Shehzad Hoosein on Ayurveda + CBD

18-Jun-2021 By Danielle Masterson

Ayurveda is an ancient eastern medical practice that’s been around over 5 thousand years. And while CBD isn’t anything new, modern medicine has only recently began conducting research.

The challenges with CBD for sports nutrition

17-Jun-2021 By Shane Starling

The CBD sports nutrition sector had its game significantly boosted in 2018 when the World Anti-Doping Agency (WADA) removed the hemp-derived cannabinoid from its list of banned performance-enhancing substances – the market duly took off.

COVID-19 and legal chaos dent CBD market – but Congress and a stronger economy offer hope

16-Jun-2021 By Shane Starling

The COVID-19 pandemic and ongoing legal quagmire surrounding CBD supplements and foods in the US have knocked what was a booming category – along with scarce science and raw material pricing and QC concerns – but the sector is looking to economic and...

'A defining moment for the industry': DSM enters CBD space with Mile High Labs partnership

15-Jun-2021 By Stephen Daniells

Royal DSM has entered into a broad commercial partnership with Colorado-based cannabinoid company Mile High Labs (MHL) for next generation science-backed cannabinoid solutions.

Virtual Natural Products Expo West

Does a drop in CBD sales signal dwindling consumer interest, or is it a classic ‘crossing the chasm’ moment?

10-Jun-2021 By Elizabeth Crawford

With US retail sales of cannabidiol-infused foods, beverages and supplements declining sharply in the past year and some early-adopters souring on the ingredient after experiencing lackluster ‘results,’ some players in the space are discontinuing their...

Industry watchdog: Over half of CBD products for pets make incorrect label claims

25-May-2021 By Danielle Masterson

The CBD pet product category has been steadily growing in popularity. Are inaccurate label claims holding it back?

Bipartisan Senate CBD bill introduced

19-May-2021 By Hank Schultz

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

UK CBD market ‘the world’s second largest behind US’, association body claims

06-May-2021 By Oliver Morrison

Consumer demand for CBD products has soared during lockdown, according to the Association for the Cannabinoid Industry (ACI), which estimates the sector will generate £690 million in annual sales this year, above a previous forecast of £526 million.

UNPA's Israelsen on DSHEA 2.0 & CBD: ‘Unless there is unity, it just gets harder’

29-Apr-2021 By Stephen Daniells

Proposed modernizations to the Dietary Supplement Health and Education Act (DSHEA) and solutions to the CBD issue require “an outstanding effort by industry to speak with a united voice”, says Loren Israelsen, President of the United Natural Products...

CBD watchdog finds 25% of products don’t test for microbials, pesticides, or heavy metals

27-Apr-2021 By Danielle Masterson

A report from a watchdog group found found that just 42% of CBD brands tested all their products for potency. Additionally, the vast majority of products tested were outside the limits of acceptable variance.

Is pain relief from CBD all in your head? Researchers put placebo effect to the test

26-Apr-2021 By Danielle Masterson

About 14% of Americans reported using CBD products—and the number one reason is pain.

New study evaluates the impact of CBD on sleep

20-Apr-2021 By Danielle Masterson

As many as 70 million Americans aren't getting enough sleep. Could CBD help them?

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

20-Apr-2021 By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

14-Apr-2021 By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...

NPA’s Fabricant on CBD, NDI-related import alerts, and banned stimulants

01-Apr-2021 By Stephen Daniells

Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.

Caution replaces euphoria as hemp event attendees wrestle with changing market

29-Mar-2021 By Hank Schultz

The CBD/hemp markets, both in finished goods and on the supply side, are in a state of transition, attendees at an industry event learned on Friday. The message was that some growers and some finished product marketers are likely to fall by the wayside...

CBD safety: Large-scale study finds no evidence of liver toxicity from oral CBD products

23-Mar-2021 By Stephen Daniells

Colorado-based ValidCare has announced the preliminary findings from its industry-sponsored, decentralized human safety study of hemp derived CBD products, with the data indicating no liver toxicity.

Love Hemp lands major deal with UFC, named official global CBD partner

18-Mar-2021 By Danielle Masterson

A UK-based CBD and hemp supplier has inked a deal with a prominent mixed martial arts organization, a move that underscores fighters and MMA organizations normalizing and embracing the use of CBD.

Folium Biosciences becomes latest US firm to submit CBD Novel Food application in UK

18-Mar-2021 By Will Chu

Folium Biosciences has become another US-based firm to submit a Novel Foods application to the UK for its cannabidiol (CBD)-based oil in response to the 31 March deadline set by the country’s food authority.

CBD novel foods deadline delayed amid last minute applications

12-Mar-2021 By Nikki Hancocks

The FSA (Food Standards Agency) has backtracked on its initial expectation for companies to make their novel foods applications at least five weeks in advance of the deadline and confirmed that it will accept applications up until March 31st, after receiving...

Misguided CBD brands in last minute novel foods panic, ACI warns

01-Mar-2021 By Nikki Hancocks

Many UK CBD brands have been misled on how to prepare for the looming novel foods deadline meaning there is less than one month for some to pull together potentially impossible amounts of data, an industry expert has warned.

New US Hemp Authority standard spells out ‘broad’ and ‘full spectrum’ specs

22-Feb-2021 By Hank Schultz

The US Hemp Authority has released the latest version of its certification standard whose aim is to promote best practices and heighten transparency among hemp companies.

Pet supplement sales surged 21% in 2020: Report

16-Feb-2021 By Stephen Daniells

Mirroring the human dietary supplement category, sales of pet supplements also skyrocketed in 2020, with Packaged Facts reporting that growth rates quadrupling in 2020 from 2019.

Caliper says university study backs bioavailability of its CBD formulations

10-Feb-2021 By Danielle Masterson

The study marks the first time humans were included in a peer-reviewed investigation of commercially available CBD product pharmacokinetics. Previous CBD studies have generally based their claims on animal model studies.

Quicksilver Scientific offers novel delivery technology for Molson Coors' first US CBD beverage line

08-Feb-2021 By Danielle Masterson

The company that specializes in liposomal delivery systems says it intends to disrupt the CBD beverage industry via its patent-pending nanoemulsion delivery technology.

Editor's Spotlight: Startup Focus

Startup introduces CBD to mainstream sports nutrition audience

08-Feb-2021 By Nikki Hancocks

A UK startup says 2021 will be the year CBD goes mainstream after launching a vegan, all-natural CBD sports nutrition brand to cater to the masses.

Representatives Schrader and Griffith re-introduce bipartisan CBD bill

05-Feb-2021 By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act has been re-introduced in the US House of Representatives with the aim of making hemp and hemp-derived CBD a dietary ingredient in dietary supplements.

Meta-analysis spotlights CBD’s stress relief capacity

04-Feb-2021 By Lynda Searby

In the last two years there has been a great wealth of evidence to support the use of CBD for anxiety and stress, according to a meta-analysis by Nutrition Formulators.

FDA yanks pending CBD enforcement proposal

27-Jan-2021 By Danielle Masterson

The White House Office of Management and Budget pulled six FDA guidances and rules from its review, including the proposal "Cannabidiol Enforcement Policy; Draft Guidance for Industry" — handing the CBD industry yet another setback.

Surveys suggest veterinarians not meeting pet nutraceutical needs

20-Jan-2021 By Danielle Masterson

While veterinarians may be able to diagnose diseases and perform difficult surgeries, many have received little education on animal nutrition.

CBD encapsulation and dual delivery: Researchers say new process significantly increases short-term bioavailability

20-Jan-2021 By Gary Scattergood

Researchers in Australia say they have been able to significantly increase the short-term bioavailability of cannabidiol (CBD) in the blood and brain thanks to a new encapsulation technique, and the combined delivery with a ‘absorption enhancer’ - Deoxycholic...

NutraVideo: Green Point Research on new 32-acre hemp campus

11-Jan-2021 By Danielle Masterson

Green Point Research (GPR) recently announced that it is expanding its footprint following the purchase of a 32-acre campus in Florida’s Hamilton County.

FDA progress report on CBD ‘nothing more than an end-of-Administration desk-clearing exercise,’ says CRN

11-Jan-2021 By Elaine Watson

For food & supplement brands hoping 2021 might be the year the FDA unveils a long-awaited regulatory framework for CBD, its Jan 7 progress report citing the need for more safety data does not provide much encouragement, with the Council for Responsible...

FTC enforcement action targets six CBD firms over unsubstantiated claims

17-Dec-2020 By Hank Schultz

The Federal Trade Commission unveiled an enforcement action today against six sellers of CBD products that it alleges have been making unsubstantiated disease treatment claims. FTC has levied more than $246,000 in fines in the cases.

NutraCast Podcast: Attorney Durkin on the 'Race to Market'

11-Dec-2020 By Danielle Masterson

Attorney Bob Durkin said that he regularly comes across clients who are curious about the prospects of studying an ingredient for use in both food and drugs.

NutraCast Podcast: Leafreport reveals disappointing findings on CBD edibles market

04-Dec-2020 By Danielle Masterson

CBD Watchdog Leafreport recently partnered with Canalysis Labs to test the potency of edibles, one of the fastest growing categories within the CBD market. As with its previous reports, product labels did not match the amount of CBD indicated in the lab...